Medical Oncology

Prof. Dr. Fatih Teker

Doctor and researcher Liv Hospital Gaziantep Gaziantep
Breast NeoplasmsStomach NeoplasmsColorectal Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 6 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Stomach Neoplasms 3 publications
  • Colorectal Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: livhospital.com.

  • Meme kanseri
  • Akciğer kanseri
  • Mide-Bağırsak kanseri, Pankreas kanseri
  • Rahim kanseri, Over kanseri
  • Prostat kanseri, Böbrek-Mesane kanseri, Testis kanseri
  • Cilt kanseri, Beyin kanseri ve diğer kanserler
  • Kanser tedavisinde;
  • Destek tedavisi
  • Kemoterapi
  • Ağrı tedavisi
  • Beslenme tedavisi
  • Moleküler tedaviler
  • İmmünolojik tedavi

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologylivhospital.comFrom source
  • InstitutionLiv Hospital Gazianteplivhospital.comFrom source
  • Area of workBreast NeoplasmsExtracted from 6 publications · Model version —From source
  • Publications95 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 21:00https://www.livhospital.com/prof-dr-fatih-tekerlivhospital.com

Scientific work

Publications on Breast Neoplasms

95 publications

  1. Evaluation of the efficacy and tolerability of bevacizumab-based treatments in recurrent primary brain tumors: a multicenter real-world Turkish Oncology Group (TOG) study

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15725-9 PMID 41691201 Open-access full textSource: OpenAlex

  2. Comparable Access, Different Outcomes: Breast Cancer Survival Among Syrian Refugees and Turkish Patients in Türkiye

    Current Oncology, 2026

    DOI 10.3390/curroncol33030155 PMID 41892183 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  3. Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients

    Istanbul Medical Journal, 2024

    DOI 10.4274/imj.galenos.2024.96266 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  4. The results of adding immunotherapy to chemotherapy in patients with small cell lung cancer: Registurk-Lung study—Real-world data.

    Journal of Clinical Oncology, 2024

    DOI 10.1200/jco.2024.42.16_suppl.e20006 Open-access full textSource: OpenAlex

  5. Assessment of the Clinicopathologic Characteristics and Survival Rates of Colorectal Cancer Among Syrian Refugees and Turkish Population in Gaziantep Province

    JCO Global Oncology, 2024

    DOI 10.1200/go.24.00211 PMID 39509657 Open-access full textSource: OpenAlex

  6. Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy

    BMC Cancer, 2023

    DOI 10.1186/s12885-023-10609-8 PMID 36765293 18 citations (Europe PMC) Open-access full textSource: OpenAlex

  7. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

    Future Oncology, 2023

    DOI 10.2217/fon-2022-1287 PMID 37133230 22 citations (Europe PMC) Open-access full textSource: OpenAlex

  8. First-line treatment of patients with HER2-positive metastatic gastric and gastroesophageal carcinoma

    Bosnian Journal of Basic Medical Sciences, 2022

    DOI 10.17305/bjbms.2021.7069 PMID 35460397 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Efficacy and Safety Profile of COVID-19 Vaccine in Cancer Patients: A Prospective, Multicenter Cohort Study

    Future Oncology, 2022

    DOI 10.2217/fon-2021-1248 PMID 35081732 27 citations (Europe PMC) Open-access full textSource: OpenAlex

  10. Comparison of 68Ga-FAPI PET/CT and 18FDG PET/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement

    Molecular Imaging and Biology, 2022

    DOI 10.1007/s11307-022-01729-x PMID 35411447 35 citations (Europe PMC) Source: OpenAlex

View all 95 publications